Estimates
Source: S&P Capital IQ consensus via Xpressfeed · Generated 2026-07-22.
FY2027 headline tape rests on one analyst
EBITDA has 8 FY2027 estimates, but revenue and normalized EPS each have 1; read the momentum table as a single-contributor move.
FY2027 revenue and normalized EPS jump 18% and 33% in 30 days
FY2028 is unchanged over 30 days, but 90-day revenue and normalized EPS estimates are down 4% and 9%.
Currency: INR · Scale: money in millions, absolute · Point-in-time consensus; Δ90d is Now versus 90d.
| Metric | FY | 180d | 90d | 30d | Now | Δ90d |
|---|---|---|---|---|---|---|
| EPS (normalized) | FY2027 | ₹20.77 | ₹20.11 | ₹18.98 | ₹25.20 | +25.3% |
| EPS (normalized) | FY2028 | ₹25.84 | ₹24.68 | ₹22.49 | ₹22.49 | -8.9% |
| Revenue | FY2027 | ₹15.88bn | ₹15.02bn | ₹14.95bn | ₹17.59bn | +17.1% |
| Revenue | FY2028 | ₹19.32bn | ₹18.30bn | ₹17.62bn | ₹17.62bn | -3.7% |
Latest quarter: normalized EPS beats 2.9% while revenue misses 31.3%
Current sequences by metric: Revenue: 2 consecutive misses; EPS (normalized): 1 consecutive beat.
Currency: INR · Scale: money in millions, absolute · Consensus is captured before each actual first became effective.
| Quarter | Metric | Consensus | Actual | Surprise | Outcome |
|---|---|---|---|---|---|
| Q1 FY2027 | Revenue | ₹2.79bn | ₹1.92bn | -31.3% | Miss |
| Q1 FY2027 | EPS (normalized) | ₹2.80 | ₹2.88 | +2.9% | Beat |
| Q4 FY2026 | Revenue | ₹4.06bn | ₹3.39bn | -16.5% | Miss |
| Q4 FY2026 | EPS (normalized) | ₹5.40 | ₹4.34 | -19.6% | Miss |
| Q3 FY2026 | Revenue | ₹2.98bn | ₹3.44bn | +15.4% | Beat |
| Q3 FY2026 | EPS (normalized) | ₹4.15 | ₹3.97 | -4.3% | Miss |
| Q2 FY2026 | Revenue | ₹2.52bn | ₹2.52bn | +0.3% | Beat |
| Q2 FY2026 | EPS (normalized) | ₹3.75 | ₹3.34 | -10.9% | Miss |
| Q1 FY2026 | Revenue | ₹2.86bn | ₹1.88bn | -34.2% | Miss |
| Q4 FY2025 | Revenue | ₹4.55bn | ₹2.06bn | -54.7% | Miss |
| Q4 FY2025 | EPS (normalized) | ₹5.30 | ₹3.44 | -35.1% | Miss |
| Q3 FY2025 | Revenue | ₹1.97bn | ₹1.62bn | -18.0% | Miss |
| Q2 FY2025 | Revenue | ₹3.14bn | ₹1.69bn | -46.2% | Miss |
| Q2 FY2025 | EPS (normalized) | ₹3.20 | ₹2.36 | -26.2% | Miss |
FY2028 EBITDA views diverge sharply despite 12 analysts
Normalized EPS also carries a wide low-to-high range, while FY2029 EBITDA spans 3,268 to 11,553 on only 5 analysts.
Currency: INR · Scale: money in millions, absolute · Spread/mean is absolute high-low divided by absolute mean.
| Metric | Period | Mean | Low–high | Spread/mean | Analysts |
|---|---|---|---|---|---|
| EBITDA | FY2028E | ₹4.77bn | ₹3.27bn–₹6.99bn | 78.2% | 12 |
| EPS (normalized) | FY2028E | ₹22.49 | ₹16.80–₹33.45 | 74.0% | 12 |
| EBITDA | FY2029E | ₹7.16bn | ₹3.27bn–₹11.55bn | 115.6% | 5 |
Growth expectations reaccelerate in FY2029 while gross margin eases
The mean tape shows near-flat revenue and lower normalized EPS in FY2028 before both rise in FY2029; EBITDA increases in each year.
Currency: INR · Scale: money in millions, absolute · YoY uses the prior fiscal year from the feed; analyst count and range use the first displayed period.
| Metric | FY2027E | FY2028E | FY2029E | YoY | Analysts | Low / high |
|---|---|---|---|---|---|---|
| Revenue | ₹17.59bn | ₹17.62bn | ₹25.20bn | +56.5% | 1 | ₹17.59bn / ₹17.59bn |
| EBITDA | ₹3.70bn | ₹4.77bn | ₹7.16bn | +21.5% | 8 | ₹3.48bn / ₹3.97bn |
| EPS (normalized) | ₹25.20 | ₹22.49 | ₹34.62 | +80.8% | 1 | ₹25.20 / ₹25.20 |
| Gross margin | 49.4% | 49.5% | 48.8% | +0.7pt | — | — |
All 12 recommendations are positive; targets span INR 425-610
The mix is 11 Buy and 1 Outperform, with no Hold, Sell or Underperform ratings.
Currency: INR · Scale: money in millions, absolute · Analyst counts shown explicitly.
| Street view | Reading | Analysts |
|---|---|---|
| Recommendation mix | Buy 11, Outperform 1, Hold 0, Underperform 0, Sell 0 | 12 |
| Consensus score | 1.08 | 12 |
| Target price | mean ₹516.8; median ₹516.0; high ₹610.0; low ₹425.0 | 12 |